The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
The Course of Myasthenia Gravis and Therapies Affecting Outcomea
Abstract
The course of 1,487 patients with myasthenia gravis followed between 1940 and 1985 for a mean of 18 years provides further evidence that the distribution, severity, and outcome of the disease are determined during the first 1 to 3 (occasionally 5) years after onset, suggesting that injury to acetylcholine receptors occurs mainly during this time. In 14%, the disease remained clinically localized to the extraocular muscles, and in the remaining 86% became generalized, in 87% within a year, with the disease reaching maximum severity within the first year after onset of symptoms in 55%, during the first 3 years in 70%, and during the first 5 years in 85%. Male patients tended to have more rapid progression of disease, higher mortality, and lower rates of remission and improvement than females. From 1940 to 1957, when management relied on anticholinesterase compounds, endotracheal intubation or tracheostomy and negative pressure assisted ventilation for respiratory failure, and thymectomy in 26% of patients and thymomectomy in 8%, 31% of patients with generalized myasthenia gravis died of the disease (29% of these during the first year after onset, 27% during the second and third years, and 17% during the fourth and fifth years), 32% improved, 23% remained unchanged, 10% went into remission, and only 5% were worse during the last year seen than during the worst of the first 3 years (or 5 years in the minority of patients who reached maximum weakness after 3 years). From 1958 to 1965, during which time the management of respiratory failure was improved by positive pressure and volume controlled ventilation and improved intensive care, mortality fell to 14% (p less than 0.005), and a higher proportion remained unchanged (p less than 0.005). From 1966 to 1985, when over half the patients received adrenal cortical steroids, mortality fell to 7% (p less than 0.005) and the proportion who improved rose to 47% (p less than 0.05). Even though the patients who received steroids usually had more severe myasthenia, they had a higher rate of improvement than those who received no steroid, 54% compared to 39% (p less than 0.005). Thymectomy was performed in one-fourth of patients with generalized myasthenia gravis, more frequently in young females and those with more severe weakness, and less often in older males and those with less severe weakness.(ABSTRACT TRUNCATED AT 400 WORDS)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
LINDSTROM, J. M., SEYBOLD, M. E., LENNON, V. A., WHITTINGHAM, S., & DUANE, D. D. (1976) · Neurology · doi:10.1212/wnl.26.11.1054 · Cited by 1,186
Autoimmune Response to Acetylcholine Receptor
Patrick, J., & Lindstrom, J. (1973) · Science · doi:10.1126/science.180.4088.871 · Cited by 1,043
MYASTHENIA GRAVIS AND TUMORS OF THE THYMIC REGION: REPORT OF A CASE IN WHICH THE TUMOR WAS REMOVED
BLALOCK, A., MASON, M. F., MORGAN, H. J., & RIVEN, S. S. (1939) · Annals of Surgery · doi:10.1097/00000658-193910000-00005 · Cited by 494
Plasmapheresis and Immunosuppressive Drug Therapy in Myasthenia Gravis
Dau, P. C., Lindstrom, J. M., Cassel, C. K., Denys, E. H., Shev, E. E., & Spitler, L. E. (1977) · New England Journal of Medicine · doi:10.1056/nejm197711242972102 · Cited by 402
Eine neue Klasse von Desinfektionsmitteln
Domagk, G. (1935) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/s-0028-1129654 · Cited by 346
TREATMENT OF MYASTHENIA GRAVIS WITH PHYSOSTIGMINE
Walker, M. B. (1934) · The Lancet · doi:10.1016/s0140-6736(00)94294-6 · Cited by 336
Experimental autoimmune myasthenia: A model of myasthenia gravis in rats and guinea pigs.
Lennon, V. A., Lindstrom, J. M., & Seybold, M. E. (1975) · The Journal of experimental medicine · doi:10.1084/jem.141.6.1365 · Cited by 335
A PROPHYLACTIC AGAINST RESPIRATORY INFECTIONS?
(1965) · The Lancet · doi:10.1016/s0140-6736(65)90936-0 · Cited by 247
AN EVALUATION OF THYMECTOMY IN MYASTHENIA GRAVIS
SIMPSON, J. A. (1958) · Brain · doi:10.1093/brain/81.1.112 · Cited by 238
Oosterhuis, H. J. G. H. (1964) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(64)90171-6 · Cited by 194
Cited by
Drachman, D. B. (1994) · New England Journal of Medicine · doi:10.1056/nejm199406233302507 · Cited by 1,139
Lifetime course of myasthenia gravis
Grob, D., Brunner, N., Namba, T., & Pagala, M. (2008) · Muscle & Nerve · doi:10.1002/mus.20950 · Cited by 733
Self-citationGronseth, G. S., & Barohn, R. J. (2000) · Neurology · doi:10.1212/wnl.55.1.7 · Cited by 576
ESPEN guideline clinical nutrition in neurology
Burgos, R., Bretón, I., Cereda, E., Desport, J. C., Dziewas, R., Genton, L., Gomes, F., Jésus, P., Leischker, A., Muscaritoli, M., et al. (2018) · Clinical Nutrition · doi:10.1016/j.clnu.2017.09.003 · Cited by 571
Metadata
- Authors
- GROB, D., ARSURA, E. L., BRUNNER, N. G., & NAMBA, T.
- Venue
- Annals of the New York Academy of Sciences
- Publisher
- Wiley
- Published
- 1987-08
- Volume
- 505
- Issue
- 1
- Pages
- 472-499
- ISSN
- 0077-8923 (ISSN-L)
- 1749-6632
- OpenAlex
- W1974589714
- Cited by
- 351
- References
- 24
- FWCI
- 4.14
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Course of Myasthenia Gravis and Therapies Affecting Outcomea. https://app.cochat.ai/papers/10.1111/j.1749-6632.1987.tb51317.x
- The paper
- GROB, D., ARSURA, E. L., BRUNNER, N. G., & NAMBA, T. (1987). The Course of Myasthenia Gravis and Therapies Affecting Outcomea. Annals of the New York Academy of Sciences. https://doi.org/10.1111/j.1749-6632.1987.tb51317.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.